Evidence map›Paper›PMID 31660406›Full record

ArticleOpen forum infectious diseases2019

The Effect of Antiretroviral Therapy Initiation on the Vaginal Microbiome in HIV-Infected Women.

Cindy M Liu, Zoe R Packman, Alison G Abraham, David M Serwadda, Fred Nalugoda, Maliha Aziz, Jessica L Prodger, Rupert Kaul, Sarah Kalibbala, Ronald H Gray and 4 more

Abstract read
In one paragraph

Article in Open forum infectious diseases, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed.

  1. Trial
  2. Observational
  3. Review
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. The Microbiome-Immune Axis Therapeutic Effects in Cancer Treatments.Journal of microbiology and biotechnology · 2022
    Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Cindy M LiuDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC.
Zoe R PackmanDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Alison G AbrahamDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
David M SerwaddaRakai Health Sciences Program, Kalisizo, Uganda.
Fred NalugodaRakai Health Sciences Program, Kalisizo, Uganda.
Maliha AzizDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC.
Jessica L ProdgerDepartment of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada.
Rupert KaulDepartment of Medicine, University of Toronto, Toronto, Ontario, Canada.
Sarah KalibbalaRakai Health Sciences Program, Kalisizo, Uganda.
Ronald H GrayDepartment of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland.
Lance B PriceDepartment of Environmental and Occupational Health, Milken Institute School of Public Health, George Washington University, Washington, DC.
Thomas C QuinnDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.
Aaron Ar TobianDepartment of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Steven J ReynoldsDepartment of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland.

Funding

Unlocking the Potential of HIV-Infected Deceased Donors for Organ TransplantationR01AI120938 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2016 to 2021
$4.3M
The role of penile bacteria and inflammation in HIV susceptibility; Rakai, UgandaR01AI123002 · NIAID · GEORGE WASHINGTON UNIVERSITY · PI LIU, CINDY · 2016 to 2020
$3.3M
Penile Microbiome, Inflammation and HIV Susceptibility During Sexual Debut and Maturation Among Male AdolescentsR01AI128779 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2017 to 2020
$2.1M
NIAID NIH HHS R01 AI120938NIAID NIH HHS R01 AI123002NIAID NIH HHS R01 AI128779
6 · The paper itself

Abstract

backgroundThe impact of antiretroviral therapy (ART) initiation on the vaginal microbiome is unknown. This is of particular importance among women living in sub-Saharan Africa. Understanding this relationship could help elucidate if and how the host immune system interacts with the vaginal microbiome.

methodsThe vaginal microbiome of HIV-1/HSV-2-coinfected women (n = 92) in Uganda was evaluated from self-collected vaginal swabs 1 month pre-ART and at 4 and 6 months post-ART initiation. The vaginal microbiome was characterized by 16S rRNA gene-based sequencing and quantitative polymerase chain reaction. Vaginal community state types (CSTs) were identified using proportional abundance data. Changes in microbiome composition were assessed with permutational analyses of variance (PerMANOVA).

resultsFive vaginal CSTs were identified, which varied significantly by bacterial load (

conclusionsThe vaginal microbiome of HIV-infected women was not affected by the initiation of ART or immune reconstitution in this observational study. Further research is needed to explore the long-term effects of ART treatment on the vaginal microbiome.

Indexed as

anaerobesantiretroviral therapyHIVmicrobiomevaginal dysbiosis

Identifiers

PMID31660406
PMCPMC6798248

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.